[July 31, 2015]

Research and Markets: UK Clinical Chemistry and Immunodiagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Research and Markets (http://www.researchandmarkets.com/research/gpssv6/20152019_uk) has announced the addition of the "2015-2019 UK Clinical Chemistry and Immunodiagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report to their offering.

2015-2019 UK Clinical Chemistry and Immunodiagnostics Market is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the UK market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, incuding controls, calibrators and consumables.

Strategic Recommendations

- New product development opportunities with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

- The companies analyzed in the report include Abbott, AdnaGen, Agilent (News - Alert), Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex, Ortho-Clinical Diagnotics, Roche, Siemens (News - Alert), Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE.

Tests Analyzed in the Report:

- Routine Clinical Chemistry

- Therapeutic Drug Monitoring (TDM)

- Endocrine Function

- Tumor Markers and Special Chemistry

- Immunoproteins

- Drugs of Abuse

Market Segmentation Analysis

- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:

- Hospitals

- Commercial/Private Laboratories

Current and Emerging Products

- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison of high, medium, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging technologies, and their potential market applications.

- Comprehensive lists of companies developing or marketing new technologies and products by test.

For more information visit http://www.researchandmarkets.com/research/gpssv6/20152019_uk

View source version on businesswire.com: http://www.businesswire.com/news/home/20150731005249/en/

[ Back To TMCnet.com's Homepage ]